Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.

NCT06866418 is registered in ClinicalTrials.gov with Phagenesis Ltd. as lead sponsor.

NCT NCT06866418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06866418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.
Lead sponsor
Phagenesis Ltd.
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 30, 2036
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dysphagia